Targeting ST14: A Promising Approach To Therapeutic Treatments

Target Name: ST14

NCBI ID: G6768

ST14

Targeting ST14: A Promising Approach To Therapeutic Treatments

ST14 (Membrane-type serine protease 1) is a protein that is expressed in a variety of cell types, including the liver, pancreas, and blood cells. It is a 25kDa protein that belongs to the serine protease family 14. ST14 is involved in the regulation of various cellular processes, including cell signaling, inflammation, and tissue repair.

One of the key functions of ST14 is its role in cell signaling. ST14 has been shown to be involved in the regulation of T cell development and function. ST14 has been shown to play a role in the regulation of T cell receptor (TCR) signaling, which is important for the development and activation of T cells.

Another function of ST14 is its role in inflammation. ST14 has been shown to be involved in the regulation of inflammation in various tissues, including the liver and the pancreas. ST14 has been shown to play a role in the regulation of immune cell function, as well as the regulation of inflammation.

In addition to its role in cell signaling and inflammation, ST14 is also involved in tissue repair. ST14 has been shown to play a role in the regulation of tissue repair and regeneration, including the regulation of cell proliferation and the formation of new tissues.

Given its involvement in so many cellular processes, ST14 is an attractive drug target. Researchers have been studying ST14 for potential therapeutic applications in a variety of diseases, including cancer, autoimmune diseases, and neurodegenerative diseases.

One potential approach to targeting ST14 is to use small molecules that can inhibit its activity. Researchers have been shown that inhibitors of ST14 have the potential to be effective in treating a variety of diseases, including cancer, autoimmune diseases, and neurodegenerative diseases.

Another potential approach to targeting ST14 is to use antibodies that can specifically recognize and target ST14. Researchers have been shown that antibodies against ST14 have the potential to be effective in treating a variety of diseases, including cancer, autoimmune diseases, and neurodegenerative diseases.

In conclusion, ST14 is a protein that is involved in a variety of cellular processes, including cell signaling, inflammation, and tissue repair. As a drug target, ST14 has the potential to be effective in treating a variety of diseases. Researchers are currently studying the potential of inhibitors and antibodies to target ST14, with the hope of developing new and effective therapies.

Protein Name: ST14 Transmembrane Serine Protease Matriptase

Functions: Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing

The "ST14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ST14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets